Literature DB >> 1111472

IgD multiple myeloma. Review of 133 cases.

Z Jancelewicz, K Takatsuki, S Sugai, W Pruzanski.   

Abstract

One hundred thirty-three patients had IgD myeloma. The IgD comprises 0.8% of M-components in general and 2.1% of myelomas in particular. Males predominate and 65% of the patients are younger than 60 years at the diagnosis. More than half of the patients have lymphadenopathy, hepatomegaly, or splenomegaly. Extraosseous spread and amyloidosis are frequent. Severe anemia and azotemia are common. Total serum protein and IgD M-component levels are usually not high. LAMBDA-type light chains are found in 90% of IgD M-components. Bence Jones proteinimia is frequent and Bence Jones proteinuria appears in almost all patients. Mean survival is 13.7 months from diagnosis. The IgD is different from IgG and IgA myeloma, indicating that the clinical picture and course of multiple cyeloma may be related to the class and type of M-component.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1111472

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  41 in total

Review 1.  Immunoglobulin D: properties, measurement, and clinical relevance.

Authors:  A O Vladutiu
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

Review 2.  New insights into the enigma of immunoglobulin D.

Authors:  Kang Chen; Andrea Cerutti
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

3.  Muscle Hypertrophy in a Patient with Immunoglobulin D Multiple Myeloma.

Authors:  Shingo Suzuki; Yoshiyuki Ohira; Masatomi Ikusaka
Journal:  J Gen Intern Med       Date:  2016-05       Impact factor: 5.128

4.  The hen's tooth: arterial aneurysm resulting from invasion by IgD myeloma cells.

Authors:  T Cooney; E Sweeney
Journal:  Ir J Med Sci       Date:  1977-09       Impact factor: 1.568

5.  Meningeal infiltration by non-myelomatous IgD-secreting plasma cell dyscrasias.

Authors:  M Yebra; L Manzano; A de la Torre; J Hornedo; F Albarran; J L Menéndez
Journal:  Postgrad Med J       Date:  1989-08       Impact factor: 2.401

6.  Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells.

Authors:  J P Drenth; J Göertz; M R Daha; J W van der Meer
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

7.  Bulky extramedullary plasmacytomata: rare mode of relapse in myelomatosis.

Authors:  S V Davies; B Jones; C M Starkie; J A Murray
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

8.  Late relapse in IgD myeloma: value of immunohistochemistry in trephine biopsy specimens.

Authors:  P Kettle; T C Morris
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

9.  Epidemiology of the M-component immunoglobulin types of multiple myeloma.

Authors:  L J Herrinton; P A Demers; T D Koepsell; N S Weiss; J R Daling; J W Taylor; J L Lyon; G M Swanson; R S Greenberg
Journal:  Cancer Causes Control       Date:  1993-03       Impact factor: 2.506

10.  Atypical progression of multiple myeloma with extensive extramedullary disease.

Authors:  S N Jowitt; A Jacobs; P A Batman; D A Sapherson
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.